精密科学 EXAS 深 沪
等待开盘 02-07 09:30:00 美东时间
102.49
-0.170
-0.17%
华盛通- 最 高102.81
- 今 开102.33
- 成交量 59.28万股
- 最 低 101.445
- 昨 收 102.66
- 总市值 1803.82万
- 52周最高 102.81
- 市盈率 静 --
- 换手率 336.82%
- 52周最低 38.88
- 委 比 50.94%
- 总股本 0.00亿
- 历史最高 159.54
- 量 比 1.32
- 振 幅 1.33%
- 历史最低 1.10
- 每 手 1
- 风险率 20.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints
Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast higher full-year profits and steady sales growth.
01-22 22:48
Guggenheim Downgrades Exact Sciences to Neutral
Guggenheim analyst Subbu Nambi downgrades Exact Sciences (NASDAQ:EXAS) from Buy to Neutral.
2025-11-21 22:08
Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday?
Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lift Wall Street on Thursday.
2025-11-21 01:43
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics
Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum.
2025-11-20 22:37
Amazon To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-11-04 22:04
Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?
Wall Street opened the week on a mixed note on Monday.
2025-11-04 02:01
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
Earnings Preview: Exact Sciences
Exact Sciences (NASDAQ:EXAS) is gearing up to announce its quarterly earnings o...
2025-10-31 23:01
“十八罗汉”之一孙彤宇持股的癌症早筛公司“觅瑞-B”通过聆讯，24年收入、毛利双双下滑
觅瑞-B于2025年5月12日通过港交所聆讯，拟在香港主板上市，联席保荐人为中金公司和建银国际。公司专注于微小核糖核酸（miRNA）技术，从事疾病筛查诊断解决方案的全球化普及。核心产品GASTROClearTM获新加坡卫生科学局批准，用于胃癌筛查。2024年收入0.2亿美元，净亏损0.92亿美元，研发开支0.19亿美元，毛利率43.82%。
2025-05-12 19:00
Raymond James Reiterates Market Perform on Exact Sciences
Raymond James analyst Andrew Cooper reiterates Exact Sciences (NASDAQ:EXAS) with a Market Perform.
2024-09-27 00:55
